DVx (3079) FY2026 Q3 Earnings Report

Quick View

Executive Summary

For the cumulative Q3 of FY2026, revenue exceeded the plan in terms of progress, while profitability remained low, resulting in a profile of revenue growth accompanied by low profit growth. Revenue was ¥418.4B, representing a progress rate of 80.5% against the full-year forecast of ¥519.6B. Operating income was ¥1.7B (operating margin of 0.4%), ordinary income was ¥1.8B, and net income was ¥1.0B, with progress rates against the full-year forecast remaining at only 26–31% in all cases. The primary reason profit has not increased in line with the scale of revenue is the cost structure in which SG&A expenses absorb 95.6% of gross profit, compared with a gross margin of 9.4%.

Factors Affecting Performance

【Revenue】Revenue of ¥418.4B represents a progress rate of 80.5% against the full-year forecast of ¥519.6B, exceeding the standard progress pace of 75%. Although segment-level disclosure is not available, revenue itself is progressing steadily toward achievement of the plan.

【Profit and Loss】Gross profit remained at ¥39.5B (gross margin of 9.4%), and SG&A expenses of ¥37.7B absorbed 95.6% of gross profit, compressing operating income to ¥1.7B (operating margin of 0.4%). The difference from ordinary income of ¥1.8B was attributable to a minor increase from non-operating income and expenses (including interest and dividend income), with no temporary factors observed. Corporate income taxes of ¥0.8B (effective tax rate of 42.9%) were recorded against pretax income of ¥1.8B, reducing net income to ¥1.0B. While revenue is expanding in line with the plan, the low gross margin and heavy tax burden are weighing on profit, indicating a revenue-growth, profit-decline earnings structure, in which progress in operating income and net income falls substantially below revenue progress.

Key Financial Indicators

【Profitability】The operating margin of 0.4%, net profit margin of 0.2%, and ROE of 1.2% are all low, with the low gross margin of 9.4% constraining overall profitability. Under the DuPont decomposition, ROE of 1.2% is broken down into a net profit margin of 0.2% × total asset turnover of 1.655x × financial leverage of 2.90x. Although asset efficiency is at a certain level, the thin profit margin is the largest constraint.【Cash Quality】Although Operating Cash Flow (OCF) has not been disclosed, DSO reaches 79 days when accounts receivable of ¥120.8B and electronically recorded monetary claims of ¥20.8B are combined, suggesting the possibility of collection delays and increased working capital requirements accompanying revenue expansion.【Investment Efficiency】ROIC is 3.5%, indicating limited profitability relative to invested capital, with the low operating margin weighing down overall capital efficiency.【Financial Soundness】The equity ratio is 34.5%, the current ratio is 141.6%, and interest-bearing debt is small at only ¥0.09B, while interest coverage is 221x, indicating extremely limited interest burden risk. On the other hand, the primary liability is accounts payable of ¥150.0B, and the company’s reliance on operating liabilities is the main factor behind financial leverage of 2.90x.

Cash Flow Analysis

As figures from the statement of cash flows have not been disclosed, a direct evaluation of Operating Cash Flow, investing cash flow, financing cash flow, and FCF cannot be conducted. However, the balance sheet provides some insight into cash trends. Cash and deposits totaled ¥49.9B, accounting for 19.7% of total assets, indicating that a certain level of liquidity has been secured. Meanwhile, accounts receivable of ¥120.8B and electronically recorded monetary claims of ¥20.8B represent a large portion of current assets, while accounts payable of ¥150.0B is recorded at nearly the same scale, creating a structure in which operating liabilities and operating receivables are expanding in tandem. The collection period of 79 days, as indicated by DSO, suggests that working capital requirements may increase as revenue grows. Future disclosure trends will therefore be an important area to monitor in assessing the company’s actual ability to generate operating cash.

Earnings Quality

Both non-operating income and expenses and extraordinary income and expenses for the current period were small, with recurring business earnings determining the majority of performance. Non-operating income was ¥0.1B (including dividend income of ¥0.04B and interest income of ¥0.02B, among others), while non-operating expenses were ¥0.04B. Accordingly, ordinary income of ¥1.8B was nearly at the same level as operating income of ¥1.7B. Extraordinary income and extraordinary losses were also each approximately ¥0.02B and immaterial, with no substantive increase or decrease in profit attributable to temporary factors. Meanwhile, corporate income taxes of ¥0.8B represented 42.9% of pretax income of ¥1.8B, and the tax burden coefficient of 0.569 significantly compressed profit after tax. In addition, since OCF has not been disclosed despite the expansion of accounts receivable and electronically recorded monetary claims, the extent to which net income of ¥1.0B has been converted into cash receipts requires continued monitoring from the perspective of accrual quality.

Earnings Forecast and Guidance

A significant gap has emerged between revenue and profit progress against the full-year forecast. Revenue is progressing at a pace exceeding the plan, with a progress rate of 80.5%, while operating income is at 30.0%, ordinary income at 31.0%, and net income attributable to owners of the parent at 26.1%. Achieving the full-year operating income forecast of ¥5.8B will require approximately ¥4.1B of operating income in Q4 alone, equivalent to approximately 2.3 times the cumulative Q3 result of ¥1.7B. Similarly, achieving the full-year net income forecast of ¥3.95B will require approximately ¥2.9B of net income in Q4, approximately 2.8 times the cumulative Q3 result. This delay in profit progress suggests that the full-year plan may assume a substantial concentration of profit generation in the second half.

Shareholder Returns

While the dividend for Q2 of the current fiscal year was ¥0, the full-year forecast dividend is ¥50 per share, indicating a plan to concentrate dividends in the second half or at fiscal year-end. If an annual dividend of ¥50 is paid against forecast full-year EPS of ¥37.66, the payout ratio based solely on dividends would be 132.8%, exceeding 100%. This suggests that dividend funding may not be secured solely from current-period profit and may involve the use of retained earnings (¥83.6B) and other internal reserves. As no information regarding share repurchases has been confirmed, no assessment has been made of the Total Return Ratio.

Risk Factors

1. Low profitability: The gross margin of 9.4% and operating margin of 0.4% are both below the industry median operating margin of 3.3%, with SG&A expenses of ¥37.7B absorbing 95.6% of gross profit. Small fluctuations in procurement or selling prices may therefore have a direct impact on operating income.

2. Risk of delayed collection of accounts receivable: DSO of 79 days is calculated based on the combined total of accounts receivable of ¥120.8B and electronically recorded monetary claims of ¥20.8B, indicating that working capital requirements may increase as revenue expands. Although the current ratio of 141.6% exceeds 100%, it remains below the 150% level generally considered a benchmark of soundness.

3. Risk of profit concentration required to achieve the full-year forecast: Achieving the full-year operating income forecast of ¥5.8B will require operating income of approximately ¥4.1B in Q4, more than twice the cumulative result, and net income will likewise require an increase of approximately 2.8x. The planned payout ratio of 132.8% also indicates weak profit-based support for the dividend funding.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (trading)

Profitability and Returns

Both the operating margin and net profit margin are substantially below the industry median, placing profitability at the lower end of the industry.

※Source: Compiled by the Company

Key Takeaways from the Results

1. Revenue progress of 80.5% against the full-year plan is proceeding at a pace exceeding the plan, but operating income and net income progress remains at only 26–31%, indicating that profit growth has not kept pace with revenue growth, which is a notable feature of the reported results.

2. The plan requires both operating income and net income in Q4 to exceed twice the cumulative Q3 results in order to achieve the full-year forecast, making profit-generation capacity in the second half the key inflection point for performance.

3. The forecast payout ratio of 132.8% and the dividend pattern of ¥0 for Q2 indicate that the annual dividend of ¥50 is closely linked to achievement of second-half performance.

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility and, where necessary, after consulting with a professional.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q3 performance was weak relative to the full-year earnings plan, with very low operating profitability despite solid sales progress. Cumulative revenue reached ¥41.84bn, equivalent to 80.5% of the ¥51.96bn full-year forecast and modestly ahead of the standard 75% Q3 progress benchmark. Operating income was ¥174m, however, only 29.9% of the ¥581m full-year forecast. Ordinary income was ¥180m and profit attributable to owners was ¥103m, representing 26.2% of the ¥395m full-year net-income target. The resulting operating margin was 0.4%, while the net profit margin was 0.2%. Gross margin was 9.4%, leaving limited capacity to absorb SG&A expenses of ¥3.77bn. SG&A consumed 95.6% of gross profit, with salaries and allowances alone accounting for ¥1.27bn. The gap between sales progress and profit progress indicates that the company needs a substantial improvement in quarterly profitability in Q4 to deliver its guidance. Based on the remaining forecast, implied Q4 revenue is ¥10.12bn, while implied Q4 operating income is ¥407m. This would require an implied Q4 operating margin of approximately 4.0%, materially above the cumulative Q3 margin of 0.4%. Non-operating income was limited at ¥10m, including ¥4m of dividend income and ¥2m of interest income, so earnings remain principally dependent on the core distribution operation. Profit before tax of ¥181m was broadly aligned with ordinary income, with only small fixed-asset sale gains and disposal losses recorded below ordinary income. The effective tax rate was elevated at 42.9%, reducing the tax burden factor to 0.569 and constraining conversion of pre-tax profit into net income. The balance sheet is liquid on a short-term basis, with a 141.6% current ratio and ¥4.99bn of cash and deposits. At the same time, receivables of ¥12.08bn and trade payables of ¥15.00bn show that working-capital execution is central to financial resilience. The key forward implication is that guidance delivery depends on a marked Q4 recovery in gross-profit generation and fixed-cost absorption rather than additional sales volume alone.

Profitability Analysis

The reported annualized DuPont ROE is 1.6%, decomposed into a 0.2% net profit margin, 2.206x asset turnover, and 2.90x financial leverage. The weakest component is profitability rather than asset utilization: annualized asset turnover is relatively high for a medical-device distributor, but it is insufficient to offset the 0.2% net margin. Financial leverage contributes to ROE mechanically, but the balance sheet carries only ¥9m of interest-bearing debt; the reported leverage primarily reflects substantial operating liabilities, notably trade payables. Gross margin was 9.4%, and operating margin fell to only 0.4% after SG&A expenses absorbed nearly all gross profit. This is a low-gross-margin distribution model, but a sub-1% operating margin leaves earnings highly sensitive to product mix, supplier pricing, reimbursement conditions and personnel costs. Salaries and allowances were ¥1.27bn, equal to 32.3% of gross profit, making labor-cost absorption a major determinant of incremental profitability. The annualized ROIC of 3.5% is below the 5% warning threshold, indicating that present operating returns are not adequately compensating for the capital employed in the business. Interest coverage was very strong at 221.37x because interest expense was only ¥0.8m, so low returns are an operating issue rather than a financing-cost issue. The tax burden factor of 0.569 is unfavorable, while the interest burden factor of 1.041 reflects small net non-operating income rather than debt stress. Sustainable profitability improvement requires either higher gross-margin product mix, better procurement economics, or tighter control of SG&A relative to revenue growth.

Growth Assessment

Revenue progress of 80.5% at Q3 exceeds the normal 75% seasonal benchmark by 5.5 percentage points, supporting the attainability of the sales forecast. In contrast, operating-income progress of 29.9% is 45.1 percentage points below the normal Q3 benchmark, and net-income progress of 26.2% is 48.8 percentage points below it. The divergence indicates that revenue growth has not translated into adequate earnings conversion during the first nine months. To achieve guidance, Q4 operating income must reach ¥407m, more than 2.3 times cumulative Q3 operating income of ¥174m. The required implied Q4 operating margin of approximately 4.0% is roughly 3.6 percentage points above the cumulative 0.4% margin. This makes the earnings outlook highly dependent on a sharp quarter-end improvement in gross margin, sales mix, expense absorption, or a combination of these factors. The small contribution from non-operating income means the company cannot reasonably bridge the operating-income shortfall through below-the-line items. The business model's high annualized asset turnover is supportive of revenue generation, but the low gross margin means sustainable profit growth requires better unit economics rather than volume expansion alone.

Financial Health

Liquidity is adequate, with current assets of ¥22.55bn against current liabilities of ¥15.92bn, producing a current ratio and quick ratio of 141.6%. Working capital was ¥6.62bn, and cash and deposits were ¥4.99bn. Short-term liquidity is therefore supported by liquid current assets rather than inventory, which is constructive for a distribution business. Trade receivables were ¥12.08bn, or 47.8% of total assets, while trade payables were ¥15.00bn, or 59.3% of total assets. Cash plus trade receivables of ¥17.07bn exceeded trade payables by approximately ¥2.07bn, indicating that operating obligations are covered by primary liquid operating assets. Total liabilities were ¥16.55bn and total equity was ¥8.73bn, equivalent to a reported debt-to-equity ratio of 1.90x when total liabilities are used. This is below the 2.0x aggressive-leverage warning threshold, but it reflects the working-capital-intensive structure and warrants continued monitoring. Interest-bearing debt was only ¥9m, long-term loans were ¥9m, and debt/capital was 0.1%, demonstrating minimal financial-debt risk. Interest coverage of 221.37x further confirms that funding costs are not a material constraint. Goodwill of ¥265m represented only 3.0% of equity and 1.0% of total assets, limiting balance-sheet dependence on acquisition-related asset values. Intangible assets represented 1.4% of total assets, also indicating limited intangible-asset concentration. The ¥523m net defined-benefit liability and ¥171m bonus provision are relevant non-debt obligations within the liability structure.

Cash Flow Quality

The operating model requires close monitoring of working-capital discipline because trade receivables totaled ¥12.08bn and electronically recorded monetary claims totaled ¥2.08bn. The quality alert for 79 days sales outstanding is significant because it exceeds the 60-day reference level and ties a substantial share of assets to customer collection. High receivable days may be normal to some extent in medical-device distribution, where hospital and medical-institution billing cycles can be lengthy, but it increases exposure to collection timing and customer-credit conditions. The impact is that profit conversion into distributable cash can become volatile even when sales remain resilient. Trade payables of ¥15.00bn provide operating funding and partly offset the receivable balance, but this also makes liquidity sensitive to payment terms and supplier relationships. Cash and deposits of ¥4.99bn provide a meaningful liquidity buffer relative to the net trade working-capital position. No cash-flow conclusion is drawn beyond these balance-sheet indicators.

Dividend Sustainability

The full-year forecast calls for DPS of ¥50.00 and forecast EPS of ¥37.66, implying a dividend payout ratio of approximately 132.8%. This is above both the 60% sustainability benchmark and the 100% warning threshold. The forecast dividend commitment would therefore exceed forecast earnings per share by approximately ¥12.34 per share. Retained earnings of ¥8.36bn provide balance-sheet capacity, and cash and deposits of ¥4.99bn offer liquidity support. Nevertheless, the earnings-funded dividend profile is weak unless profitability recovers materially from the cumulative Q3 level. The principal determinant of dividend sustainability is whether the company can achieve the required Q4 operating-profit acceleration embedded in its full-year plan.

Risk Assessment

Business risks include Margin risk: The 9.4% gross margin and 0.4% operating margin leave earnings highly exposed to small changes in procurement terms, product mix, selling prices and reimbursement-related market conditions., Execution risk: Operating-income progress is 29.9% versus a standard 75% Q3 benchmark, requiring an implied Q4 operating margin of about 4.0% to achieve the full-year plan., Medical-device distribution risk: Customer demand patterns, hospital purchasing cycles, supplier relationships and competitive tendering can pressure pricing and gross-margin stability., Receivables risk: DSO of 79 days exceeds the 60-day reference point, increasing sensitivity to collection delays and customer-credit deterioration..

Financial risks include Working-capital funding risk: Trade payables of ¥15.00bn are a major source of operating funding; a reduction in supplier credit terms could tighten liquidity., Return risk: Annualized ROIC of 3.5% and annualized ROE of 1.6% are below standard capital-efficiency thresholds., Tax-conversion risk: The 42.9% effective tax rate reduced the tax burden factor to 0.569, suppressing net-income conversion from pre-tax profit..

Key concerns include LOW_OPERATING_EFFICIENCY: The 0.4% EBIT margin is materially below the 5% concern threshold. Its root cause is that SG&A of ¥3.77bn consumed nearly all ¥3.95bn of gross profit. In a low-margin distributor this can occur when fixed personnel and operating costs are not sufficiently absorbed, but the impact is a very narrow earnings buffer and elevated sensitivity to modest cost or pricing changes., LOW_GROSS_MARGIN: The 9.4% gross margin is below the 20% broad benchmark. This is partly consistent with a distribution-oriented business model, but the impact is that operating leverage works adversely when SG&A cannot be flexed quickly., CAPITAL_EFFICIENCY: Annualized ROIC of 3.5% is below the 5% warning threshold. The root cause is low operating profit relative to the working-capital-intensive asset base. The impact is weak value creation unless margins or capital turnover improve., HIGH_RECEIVABLE_DAYS: DSO of 79 days is above the 60-day alert level. Medical-sector customer settlement practices can contribute to longer collection cycles, but the impact is increased cash-conversion and credit-risk sensitivity., HIGH_TAX_BURDEN: The 42.9% effective tax rate exceeds 40%, producing a 0.569 tax burden factor. The impact is that only about 57% of pre-tax income converted into net income during the period, worsening already low net profitability..

Investment Implications

Key takeaways include Sales tracking is ahead of the normal Q3 run rate, but earnings are materially behind plan., The full-year forecast requires a substantial Q4 margin recovery, with implied Q4 operating income of ¥407m and an implied operating margin of about 4.0%., Low financial debt, strong interest coverage and adequate current liquidity mitigate solvency risk., The central analytical issue is whether gross-margin and SG&A dynamics can support a durable improvement in annualized ROIC from 3.5%..

Metrics to watch include Quarterly gross margin and operating margin, Q4 operating income relative to the ¥407m implied requirement, DSO and trade receivable balance, Trade-payable terms and operating working-capital balance, Effective tax rate, Dividend payout ratio relative to achieved EPS, Annualized ROIC and ROE.

Regarding relative positioning, The company appears financially conservative in terms of interest-bearing debt and goodwill exposure, but operationally weaker than broad profitability and capital-efficiency benchmarks. Its high annualized asset turnover is characteristic of a distributor, yet the present gross-margin and SG&A structure produces subscale operating returns.